TriSalus Life Sciences: Funding, Investors & Team (Sep 2026)
The goal of TriSalus Life Sciences, an immunotherapy business, is to prolong and enhance the lives of people with liver and pancreatic malignancies. The most significant barriers that limit the effectiveness of therapeutics for liver and pancreatic tumors are immune response suppression and ineffective drug delivery caused by high intratumoral pressure, and TriSalus' organ-specific platform integrates novel therapeutics and innovative drug delivery technology to address these issues.
TriSalus Life Sciences has raised $23.5M across 1 funding round on record, the most recent a Series E of $23.5M announced in Nov 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TriSalus Life Sciences Company Profile and Key Stats
Latest funding round on record: Nov 2022.
TriSalus Life Sciences Funding Rounds
TriSalus Life Sciences Founders and Leadership Team
No contact details are on record for this team yet.
TriSalus Life Sciences Funding Compared to Other Biotechnology Startups
TriSalus Life Sciences' latest round of $23.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TriSalus Life Sciences in Biotechnology and Westminster
Companies Similar to TriSalus Life Sciences
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
TriSalus Life Sciences Funding FAQs
What does TriSalus Life Sciences do?
The goal of TriSalus Life Sciences, an immunotherapy business, is to prolong and enhance the lives of people with liver and pancreatic malignancies. The most significant barriers that limit the effectiveness of therapeutics for liver and pancreatic tumors are immune response suppression and ineffective drug delivery caused by high intratumoral pressure, and TriSalus' organ-specific platform integrates novel therapeutics and innovative drug delivery technology to address these issues.
How much funding has TriSalus Life Sciences raised?
TriSalus Life Sciences has raised $23.5M across 1 round on record. The most recent is a Series E of $23.5M announced in Nov 2022.
When did TriSalus Life Sciences last raise funding?
TriSalus Life Sciences' most recent funding round on record is a Series E of $23.5M, announced in Nov 2022.
Who is the CEO of TriSalus Life Sciences?
Mary Szela is listed as CEO at TriSalus Life Sciences.
Where is TriSalus Life Sciences headquartered?
TriSalus Life Sciences is based in Westminster, Colorado, United States.
How many employees does TriSalus Life Sciences have?
TriSalus Life Sciences is in the 51-100 employee band.
How does TriSalus Life Sciences' funding compare to other Biotechnology startups?
TriSalus Life Sciences' latest round of $23.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's TriSalus Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TriSalus Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.